title: Brimonidine effective but may lead to significant rebound erythema.
authors.affiliation: Department of Dermatology, University of Pittsburgh Medical Center, Pennsylvania. Electronic address: ilkovitchd@upmc.edu.
authors.forename: Dan
authors.initials: D
authors.lastname: Ilkovitch
authors.affiliation: Department of Dermatology, University of Pittsburgh Medical Center, Pennsylvania.
authors.forename: Rebecca G
authors.initials: RG
authors.lastname: Pomerantz
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D000068438:Brimonidine Tartrate; D004890:Erythema / Q000139:chemically induced*; D005260:Female; D006801:Humans; D011810:Quinoxalines / Q000009:adverse effects* / Q000627:therapeutic use; D012393:Rosacea / Q000188:drug therapy*; D014661:Vasoconstriction / Q000187:drug effects*
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D011810:Quinoxalines; D000068438:Brimonidine Tartrate